This downloadable paper from the Bianco lab shows in sharp focus the unwillingness to demote "normal" TSH from its spurious role as an endpoint to routinely determine satisfactory T4 monotherapy. The community still hangs on to this by its fingernails, whatever the contrary evidence. And of course, satisfaction is statistically recorded rather than individual patient's' experiences.
Levothyroxine Treatment Adequacy and Formulation Changes in Patients With Hypothyroidism: A Retrospective Study of Real-World Data From the United States
June 2023Thyroid: official journal of the American Thyroid AssociationFollow journal
DOI: 10.1089/thy.2022.0382
Antonio C. Bianco, Yanjun Bao, Oscar Antunez Flores, Todd Frieze